January 2026
1. HOFFMANN RJ, Bensen A, Dane M, Arterberry J, et al
   S-Nitrosylated COX-2 is a microenvironment-regulated breast cancer cell biomarker of mesenchymal phenotypes.
   Exp Cell Res. 2026 Jan 7:114888. doi: 10.1016/j.yexcr.2026.114888.
   

   >> Share

   
   December 2025
2. ALIREZAE P, Khoshraftar SH, Hadi S, Amirfiroozi A, et al
   Navigating the Nexus: Dysregulation of Non-Coding RNAs in Breast Cancer Under Therapeutic Interventions - Mechanisms and Clinical Implications.
   Exp Cell Res. 2025 Dec 9:114854. doi: 10.1016/j.yexcr.2025.114854.
   

   >> Share

   
   November 2025
3. LI J, Zhu X, Feng L, Liu X, et al
   Berberine overcomes paclitaxel resistance in Triple-Negative Breast Cancer by inhibiting HSP90-mediated BRCA1 phosphorylation.
   Exp Cell Res. 2025 Nov 4:114815. doi: 10.1016/j.yexcr.2025.114815.
   

   >> Share

   
   September 2025
4. GUGALAVATH S, Malla M, Podilapu AR, Lee JM, et al
   Silencing CD151 gene in donor triple-negative breast cancer cells attenuates exosome-driven functions of recipient cells.
   Exp Cell Res. 2025;452:114740.
   

   >> Share

   
   
5. WU G, Yao W, Cheng L, Wang X, et al
   SIRT1 rescues autophagic flux via PI3K/AKT/mTOR inactivation to suppress DOX-induced senescence in MCF-7 cells.
   Exp Cell Res. 2025;452:114754.
   

   >> Share

   
   August 2025
6. ZHANG M, Chen H, Zhang L, Yuan A, et al
   Cryptotanshinone instigates ferroptosis to inhibit the development of tamoxifen-resistant breast cancer via the AMPK induced BECN1-SLC7A11 complex axis.
   Exp Cell Res. 2025;451:114726.
   

   >> Share

   
   June 2025
7. KUMAI J, Sasagawa S, Yui Y
   Metastatic breast cancer cells adapt to a soft environment with limited involvement of mechanotransduction.
   Exp Cell Res. 2025;450:114629.
   

   >> Share

   
   May 2025
8. SUN X, Zang H, Li S, Kong J, et al
   EFHD1 promotes breast cancer progression through estrogen signaling.
   Exp Cell Res. 2025 May 27:114620. doi: 10.1016/j.yexcr.2025.114620.
   

   >> Share

   
   
9. GUO B, Wang K, Wu J, Yu H, et al
   Runx1 activates the transformation of adipocytes into cancer-associated adipocytes by downregulating Plin1.
   Exp Cell Res. 2025;448:114573.
   

   >> Share

   
   April 2025
10. KHAZAEI-POUL Y, Firouzjaei AA, Paryan M, Tafti A, et al
    Evaluation of the Impact of miR-3143 on the PI3K/AKT Signaling Pathway and Its Subsequent Influence on the Metastatic Phenotype of Triple-Negative Breast Cancer Cells.
    Exp Cell Res. 2025 Apr 7:114552. doi: 10.1016/j.yexcr.2025.114552.
    

    >> Share

    
    March 2025
11. KHAN SU, Cervantes-Villagrana RD, Eduardo Del Rio-Robles J, Tomas-Morales JA, et al
    Calcium sensing receptor stimulates breast cancer cell migration and invasion via protein kinase C zeta.
    Exp Cell Res. 2025;447:114523.
    

    >> Share

    
    
12. SAADH MJ, Hamid JA, Malathi H, Kazmi SW, et al
    SNHG family lncRNAs: Key players in the breast cancer progression and immune cell's modulation.
    Exp Cell Res. 2025;447:114531.
    

    >> Share

    
    February 2025
13. LIU X, Zhu Y, Huang W, Chen J, et al
    MYG1 interacts with HSP90 to promote breast cancer progression through Wnt/beta-catenin and Notch signaling pathways.
    Exp Cell Res. 2025;446:114448.
    

    >> Share

    
    December 2024
14. OZDEMIR D, Agca CA
    AZD1390, an Ataxia telangiectasia mutated inhibitor, enhances cisplatin mediated apoptosis in breast cancer cells.
    Exp Cell Res. 2024;444:114382.
    

    >> Share

    
    
15. AL-NOSHOKATY TM, El-Sayyad GS, Abdelhamid R, Mansour A, et al
    Long non-coding RNAs and their role in breast cancer pathogenesis and drug resistance: Navigating the non-coding landscape review.
    Exp Cell Res. 2024;444:114365.
    

    >> Share

    
    November 2024
16. JIAO C, Qiu J, Gong C, Li X, et al
    Ganoderma lucidum Extract Reverses Multidrug Resistance in Breast Cancer Cells through Inhibiting ATPase Activity of the P-glycoprotein via MAPK/ERK signaling pathway.
    Exp Cell Res. 2024 Nov 27:114355. doi: 10.1016/j.yexcr.2024.114355.
    

    >> Share

    
    
17. IBRAHIM FM, Saleh RO, Uinarni H, Bokov DO, et al
    Exosomal noncoding RNA (ncRNA) in breast cancer pathogenesis and therapy; two sides of the same coin.
    Exp Cell Res. 2024 Nov 26:114359. doi: 10.1016/j.yexcr.2024.114359.
    

    >> Share

    
    
18. PUROHIT S, Mandal G, Biswas S, Dalui S, et al
    AXL/GAS6 signaling governs differentiation of tumor-associated macrophages in breast cancer.
    Exp Cell Res. 2024 Nov 5:114324. doi: 10.1016/j.yexcr.2024.114324.
    

    >> Share

    
    
19. RADHA G, Pragyandipta P, Naik PK, Lopus M, et al
    The mode of action of sorafenib in MDA-MB-231 breast carcinoma cells involves components of apoptotic, necroptotic and autophagy-dependent cell death pathways.
    Exp Cell Res. 2024;443:114313.
    

    >> Share

    
    August 2024
20. XU M, Gao X, Yue L, Li J, et al
    Sensitivity of Triple Negative Breast Cancer cells to ATM-dependent Ferroptosis Induced by Sodium Selenite.
    Exp Cell Res. 2024 Aug 28:114222. doi: 10.1016/j.yexcr.2024.114222.
    

    >> Share

    
    
21. WANG X, Li P, Zhang Z, Wang X, et al
    N6-methyladenosine modification of linc-OIP5 confers paclitaxel resistance in breast cancer through a DDX5-dependent mechanism.
    Exp Cell Res. 2024 Aug 27:114226. doi: 10.1016/j.yexcr.2024.114226.
    

    >> Share

    
    
22. MA S, Pu C
    MiR-519e-5p regulates malignant phenotype of breast cancer cells through binding to CTPS1.
    Exp Cell Res. 2024 Aug 26:114225. doi: 10.1016/j.yexcr.2024.114225.
    

    >> Share

    
    
23. CHOUDHURY AR, Nagesh AM, Gupta S, Chaturvedi PK, et al
    MicroRNA signature of stromal-epithelial interactions in prostate and breast cancers.
    Exp Cell Res. 2024;441:114171.
    

    >> Share

    
    April 2024
24. SHOME R, Sen P, Sarkar S, Ghosh SS, et al
    Single-cell transcriptomics reveals the intra-tumoral heterogeneity and SQSTM1/P62 and Wnt/beta-catenin mediated epithelial to mesenchymal transition and stemness of triple-negative breast cancer.
    Exp Cell Res. 2024 Apr 5:114032. doi: 10.1016/j.yexcr.2024.114032.
    

    >> Share

    
    February 2024
25. SHI X, Sun Y, Zhang Y, Wang W, et al
    Corrigendum to "MEX3A promotes development and progression of breast cancer through regulation of PIK3CA" [Exp. Cell Res. 2021 Jul 1;404(1):112580. Epub 2021 Apr 1.].
    Exp Cell Res. 2024;436:113964.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share